A citation-based method for searching scientific literature

Thomas Hogberg, Mauro Signorelli, Carlos Freire de Oliveira, Roldano Fossati, Andrea Alberto Lissoni, Bengt Sorbe, Håkan Andersson, Seija Grenman, Caroline Lundgren, Per Rosenberg, Karin Boman, Bengt Tholander, Giovanni Scambia, Nicholas Reed, Gennaro Cormio, Germana Tognon, Jackie Clarke, Tomasz Sawicki, Paolo Zola, Gunnar Kristensen. Eur J Cancer 2010
Times Cited: 308







List of co-cited articles
921 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo,[...]. Lancet Oncol 2018
264
58

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.
R Maggi, A Lissoni, F Spina, M Melpignano, P Zola, G Favalli, A Colombo, R Fossati. Br J Cancer 2006
301
53

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
C L Creutzberg, W L van Putten, P C Koper, M L Lybeert, J J Jobsen, C C Wárlám-Rodenhuis, K A De Winter, L C Lutgens, A C van den Bergh, E van de Steen-Banasik,[...]. Lancet 2000
49

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
47


Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Marcus E Randall, Virginia L Filiaci, Hyman Muss, Nick M Spirtos, Robert S Mannel, Jeffrey Fowler, J Tate Thigpen, Jo Ann Benda. J Clin Oncol 2006
615
46

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
43

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
R A Nout, V T H B M Smit, H Putter, I M Jürgenliemk-Schulz, J J Jobsen, L C H W Lutgens, E M van der Steen-Banasik, J W M Mens, A Slot, M C Stenfert Kroese,[...]. Lancet 2010
705
42

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
Daniela Matei, Virginia Filiaci, Marcus E Randall, David Mutch, Margaret M Steinhoff, Paul A DiSilvestro, Katherine M Moxley, Yong M Kim, Matthew A Powell, David M O'Malley,[...]. N Engl J Med 2019
180
41

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.
P Blake, Ann Marie Swart, J Orton, H Kitchener, T Whelan, H Lukka, E Eisenhauer, M Bacon, D Tu, M K B Parmar,[...]. Lancet 2009
403
40

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Marcus E Randall, Virginia Filiaci, D Scott McMeekin, Vivian von Gruenigen, Helen Huang, Catheryn M Yashar, Robert S Mannel, Jae-Weon Kim, Ritu Salani, Paul A DiSilvestro,[...]. J Clin Oncol 2019
153
40

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Romerai D'Amico,[...]. Lancet Oncol 2019
183
35

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Pierluigi Benedetti Panici, Stefano Basile, Francesco Maneschi, Andrea Alberto Lissoni, Mauro Signorelli, Giovanni Scambia, Roberto Angioli, Saverio Tateo, Giorgia Mangili, Dionyssios Katsaros,[...]. J Natl Cancer Inst 2008
997
29


Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
341
28

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, J Ledermann, C Marth, R Nout, D Querleu, M R Mirza,[...]. Ann Oncol 2016
556
27


Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
246
22


Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Amanda N Fader, Dana M Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley,[...]. J Clin Oncol 2018
196
22

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo,[...]. Lancet Oncol 2016
96
21

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
370
21

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Carien L Creutzberg, Wim L J van Putten, Carla C Wárlám-Rodenhuis, Alfons C M van den Bergh, Karin A J de Winter, Peter C M Koper, Marnix L M Lybeert, Annerie Slot, Ludy C H W Lutgens, Marika C Stenfert Kroese,[...]. J Clin Oncol 2004
209
20


A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Emma C Rossi, Lynn D Kowalski, Jennifer Scalici, Leigh Cantrell, Kevin Schuler, Rabbie K Hanna, Michael Method, Melissa Ade, Anastasia Ivanova, John F Boggess. Lancet Oncol 2017
411
20

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
B G Wortman, C L Creutzberg, H Putter, I M Jürgenliemk-Schulz, J J Jobsen, L C H W Lutgens, E M van der Steen-Banasik, J W M Mens, A Slot, M C Stenfert Kroese,[...]. Br J Cancer 2018
110
20

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Tjalling Bosse, Elke E M Peters, Carien L Creutzberg, Ina M Jürgenliemk-Schulz, Jan J Jobsen, Jan Willem M Mens, Ludy C H W Lutgens, Elzbieta M van der Steen-Banasik, Vincent T H B M Smit, Remi A Nout. Eur J Cancer 2015
170
19

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
177
19

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
Nicoletta Colombo, Carien Creutzberg, Frederic Amant, Tjalling Bosse, Antonio González-Martín, Jonathan Ledermann, Christian Marth, Remi Nout, Denis Querleu, Mansoor Raza Mirza,[...]. Int J Gynecol Cancer 2016
350
18

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.
Carien L Creutzberg, Remi A Nout, Marnix L M Lybeert, Carla C Wárlám-Rodenhuis, Jan J Jobsen, Jan-Willem M Mens, Ludy C H W Lutgens, Elisabeth Pras, Lonneke V van de Poll-Franse, Wim L J van Putten. Int J Radiat Oncol Biol Phys 2011
185
18

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
331
18

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Yukiharu Todo, Hidenori Kato, Masanori Kaneuchi, Hidemichi Watari, Mahito Takeda, Noriaki Sakuragi. Lancet 2010
486
17

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
Bengt Sorbe, György Horvath, Håkan Andersson, Karin Boman, Caroline Lundgren, Birgitta Pettersson. Int J Radiat Oncol Biol Phys 2012
105
17

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
T Bosse, R A Nout, E Stelloo, E Dreef, H W Nijman, I M Jürgenliemk-Schulz, J J Jobsen, C L Creutzberg, V T H B M Smit. Eur J Cancer 2014
97
15

Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.
Joan L Walker, Marion R Piedmonte, Nick M Spirtos, Scott M Eisenkop, John B Schlaerth, Robert S Mannel, Richard Barakat, Michael L Pearl, Sudarshan K Sharma. J Clin Oncol 2012
399
14

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
Gini F Fleming, Virginia L Brunetto, David Cella, Katherine Y Look, Gary C Reid, Adnan R Munkarah, Richard Kline, Robert A Burger, Annekathryn Goodman, R Tucker Burks. J Clin Oncol 2004
389
14

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
327
14

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
13

Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
Tapio Kuoppala, Johanna Mäenpää, Eija Tomas, Ulla Puistola, Tuula Salmi, Seija Grenman, Pentti Lehtovirta, Matti Fors, Tiina Luukkaala, Pirkko Sipilä. Gynecol Oncol 2008
78
16

Prognostic significance of POLE proofreading mutations in endometrial cancer.
David N Church, Ellen Stelloo, Remi A Nout, Nadejda Valtcheva, Jeroen Depreeuw, Natalja ter Haar, Aurelia Noske, Frederic Amant, Ian P M Tomlinson, Peter J Wild,[...]. J Natl Cancer Inst 2014
188
13

Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Anthony Kong, Nick Johnson, Henry C Kitchener, Theresa A Lawrie. J Natl Cancer Inst 2012
113
13

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Angeles Alvarez Secord, Laura J Havrilesky, David M O'Malley, Victoria Bae-Jump, Nicole D Fleming, Gloria Broadwater, David E Cohn, Paola A Gehrig. Gynecol Oncol 2009
93
13

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
106
13

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
13

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
130
12

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Howard D Homesley, Virginia Filiaci, Susan K Gibbons, Harry J Long, David Cella, Nick M Spirtos, Robert T Morris, Koen DeGeest, Roger Lee, Anthony Montag. Gynecol Oncol 2009
142
12

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.
B G Wortman, T Bosse, R A Nout, L C H W Lutgens, E M van der Steen-Banasik, H Westerveld, H van den Berg, A Slot, K A J De Winter, K W Verhoeven-Adema,[...]. Gynecol Oncol 2018
94
12

The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline.
Ann Klopp, Benjamin D Smith, Kaled Alektiar, Alvin Cabrera, Antonio L Damato, Beth Erickson, Gini Fleming, David Gaffney, Kathryn Greven, Karen Lu,[...]. Pract Radiat Oncol 2014
119
12

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Vicky Makker, Drew Rasco, Nicholas J Vogelzang, Marcia S Brose, Allen L Cohn, James Mier, Christopher Di Simone, David M Hyman, Daniel E Stepan, Corina E Dutcus,[...]. Lancet Oncol 2019
266
12

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie,[...]. Mod Pathol 2015
248
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.